Role of the aryl hydrocarbon receptor in cell cycle regulation

Chemico-Biological Interactions

Volumn 141, Issue 1-2, 2002, Pages 117-130

  Puga, Alvaro ^a   Xia, Ying ^a   Elferink, Cornelis ^b  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Environmental checkpoints; Gene regulation; Polycyclic aromatic compounds; Retinoblastoma protein; Signal transduction; Transcription factors

Indexed keywords

AROMATIC HYDROCARBON RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; RETINOBLASTOMA PROTEIN;

ANIMAL CELL; ARTICLE; CELL CYCLE; HUMAN; HUMAN CELL; NONHUMAN; ONCOGENE RAS; PHOSPHORYLATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

ANIMALS; CELL CYCLE; GENE EXPRESSION REGULATION; GENES, TUMOR SUPPRESSOR; ONCOGENE PROTEINS; PHOSPHORYLATION; RECEPTORS, ARYL HYDROCARBON; SIGNAL TRANSDUCTION; XENOBIOTICS;

EID: 0037145022     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(02)00069-8     Document Type: Article

References (82)

1. Kohn K.W. Molecular interaction map of the mammalian cell cycle control and DNA repair systems. Mol. Biol. Cell. 10:1999;2703-2734.
2. Bombick D.W., Jankun J., Tullis K., Matsumura F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes increases in expression of c-erb-A and levels of protein-tyrosine kinases in selected tissues of responsive mouse strains. Proc. Natl. Acad. Sci. USA. 85:1988;4128-4132.
3. Bombick D.W., Madhukar B.V., Brewster D.W., Matsumura F. TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) causes an increase in protein kinases particularly protein kinase C in the hepatic plasma membrane of the rat and the guinea pig. Biochem. Biophys. Res. Commun. 127:1985;296-302.
4. Madhukar B.V., Ebner K., Matsumura F., Bombick D.W., Brewster D.W., Kawamoto T. 2,3,7,8-Tetrachlorodibenzo-p-dioxin causes an increase in protein kinases associated with epidermal growth factor receptor in the hepatic plasma membrane. J. Biochem. Toxicol. 3:1988;261-277.
5. Park R., Kim D.H., Kim M.S., So H.S., Chung H.T., Kwon K.B., Ryu D.G., Kim B.R. Association of Shc, Cbl, Grb2, and Sos following treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin in primary rat hepatocytes. Biochem. Biophys. Res. Commun. 253:1998;577-581.
6. Parrish A.R., Fisher R., Bral C.M., Burghardt R.C., Gandolfi A.J., Brendel K., Ramos K.S. Benzo(a)pyrene-induced alterations in growth-related gene expression and signaling in precision-cut adult rat liver and kidney slices. Toxicol. Appl. Pharmacol. 152:1998;302-308.
7. Enan E., Matsumura F. Significance of TCDD-induced changes in protein phosphorylation in the adipocyte of male guinea pigs. J. Biochem. Toxicol. 9:1994;159-170.
8. Reiners J.J., Jones C.L., Hong N., Clift R.E., Elferink C. Downregulation of aryl hydrocarbon receptor function and cytochrome P450 1A1 induction by expression of Ha-ras oncogenes. Mol. Carcinog. 19:1997;91-100.
9. Bral C.M., Ramos K.S. Identification of benzo(a)pyrene-inducible cis-acting elements within c-Ha-ras transcriptional regulatory sequences. Mol. Pharmacol. 52:1997;974-982.
10. Puga A., Maier A., Medvedovic M. The transcriptional signature of dioxin in human hepatoma HepG2 cells. Biochem. Pharmacol. 60:2000;1129-1142.
11. Ramakrishna G., Anderson L.M. Levels and membrane localization of the c-K-ras p21 protein in lungs of mice of different genetic strains and effects of 2,3,7,8- tetrachlorodibenzo-p-dioxin (TCDD) and aroclor 1254. Carcinogenesis. 19:1998;463-470.
12. Pratt W.B. The role of the hsp90-based chaperone system in signal transduction by nuclear receptors and receptors signaling via MAP kinase. Annu. Rev. Pharmacol. Toxicol. 37:1997;297-326.
13. Jyonouchi H., Sun S., Iijima K., Wang M., Hecht S.S. Effects of anti-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene on human small airway epithelial cells and the protective effects of myo-inositol. Carcinogenesis. 20:1999;139-145.
14. Enan E., El Sabeawy F., Scott M., Overstreet J., Lasley B. Alterations in the growth factor signal transduction pathways and modulators of the cell cycle in endocervical cells from macaques exposed to TCDD. Toxicol. Appl. Pharmacol. 151:1998;283-293.
15. Cobb M.H., Goldsmith E.J. Dimerization in MAP-kinase signaling. Trends Biochem. Sci. 25:2000;7-9.
16. Barbacid M. Ras genes. Annu. Rev. Biochem. 56:1987;779-827.
17. Sewall C.H., Lucier G.W., Tritscher A.M., Clark G.C. TCDD-mediated changes in hepatic epidermal growth factor receptor may be a critical event in the hepatocarcinogenic action of TCDD. Carcinogenesis. 14:1993;1885-1893.
18. Sewall C.H., Clark G.C., Lucier G.W. TCDD reduces rat hepatic epidermal growth factor receptor: comparison of binding, immunodetection, and autophosphorylation. Toxicol. Appl. Pharmacol. 132:1995;263-272.
19. Partanen A.M., Alaluusua S., Miettinen P.J., Thesleff I., Tuomisto J., Pohjanvirta R., Lukinmaa P.L. Epidermal growth factor receptor as a mediator of developmental toxicity of dioxin in mouse embryonic teeth. Lab. Invest. 78:1998;1473-1481.
20. Carrier F., Owens R.A., Nebert D.W., Puga A. Dioxin-dependent activation of murine Cypla-1 transcription requires protein kinase C-dependent phosphorylation. Mol. Cell. Biol. 12:1992;1856-1863.
21. Chen Y.H., Tukey R.H. Protein kinase C modulates regulation of the CYP1A1 gene by the aryl hydrocarbon receptor. J. Biol. Chem. 271:1996;26261-26266.
22. Long W.P., Pray-Grant M., Tsai J.C., Perdew G.H. Protein kinase C activity is required for aryl hydrocarbon receptor pathway-mediated signal transduction. Mol. Pharmacol. 53:1998;691-700.
23. A. Puga, J. Bohm, A. Hoffer, G.D. Leikauf, H.G. Shertzer, S. Zhou, Dioxin alters calcium homeostasis and the regulation of arachidonate metabolism in mouse hepatoma cells, Proceedings of the 15th International Symposium on Chlorinated Dioxins, vol. 25, 1995, pp. 381-386.
24. Puga A., Hoffer A., Zhou S., Bohm J.M., Leikauf G.D., Shertzer H.G. Sustained increase in intracellular free calcium and activation of cyclooxygenase-2 expression in mouse hepatoma cells treated with dioxin. Biochem. Pharmacol. 54:1997;1287-1296.
25. 2+ and cell proliferation in primary human mammary epithelial cells. Carcinogenesis. 18:1997;1177-1182.
26. 2+ in the MCF-10A human mammary epithelial cell line by carcinogenic polycyclic aromatic hydrocarbons. Mol. Carcinog. 25:1999;48-54.
27. Cao W., Luttrell L.M., Medvedev A.V., Pierce K.L., Daniel K.W., Dixon T.M., Lefkowitz R.J., Collins S. Direct binding of activated c-Src to the beta 3-adrenergic receptor is required for MAP kinase activation. J. Biol. Chem. 275:2000;38131-38134.
28. Watters J.J., Chun T.Y., Kim Y.N., Bertics P.J., Gorski J. Estrogen modulation of prolactin gene expression requires an intact mitogen-activated protein kinase signal transduction pathway in cultured rat pituitary cells. Mol. Endocrinol. 14:2000;1872-1881.
29. Enan E., Dunlap D.Y., Matsumura F. Use of c-Src and c-Fos knockout mice for the studies on the role of c-Src kinase signaling in the expression of toxicity of TCDD. J. Biochem. Mol. Toxicol. 12:1998;263-274.
30. Enan E., Matsumura F. Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway. Biochem. Pharmacol. 52:1996;1599-1612.
31. Enan E., Matsumura F. Evidence for a second pathway in the action mechanism of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD). Significance of Ah-receptor mediated activation of protein kinase under cell-free conditions. Biochem. Pharmacol. 49:1995;249-261.
32. Knutson J.C., Poland A. Response of murine epidermis to 2,3,7,8,-tetrachlorodibenzo-p-dioxin: interaction of the Ah and hr loci. Cell. 30:1982;225-234.
33. Poland A., Palen D., Glover E. Tumour promotion by TCDD in skin of HRS/J hairless mice. Nature. 300:1982;271-273.
34. Kim D.W., Gazourian L., Quadri S.A., Romieu-Mourez R., Sherr D.H., Sonenshein G.E. The RelA NF-kappaB subunit and the aryl hydrocarbon receptor (AhR) cooperate to transactivate the c-myc promoter in mammary cells. Oncogene. 19:2000;5498-5506.
35. Tian Y., Ke S., Denison M.S., Rabson A.B., Gallo M.A. Ah receptor and NF-kappaB interactions, a potential mechanism for dioxin toxicity. J. Biol. Chem. 274:1999;510-515.
36. Ke S., Rabson A.B., Germino J.F., Gallo M.A., Tian Y. Mechanism of suppression of Cytochrome P-450 1A1 expression by tumor necrosis factor-alpha and lipopolysaccharide. J. Biol. Chem. 276:2001;39638-39644.
37. Puga A., Barnes S.J., Chang C., Zhu H., Nephew K.P., Khan S.A., Shertzer H.G. Activation of transcription factors activator protein-1 and nuclear factor-kappaB by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Biochem. Pharmacol. 59:2000;997-1005.
38. Ashida H., Nagy S., Matsumura F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD)-induced changes in activities of nuclear protein kinases and phosphatases affecting DNA binding activity of c-Myc and AP-1 in the livers of guinea pigs. Biochem. Pharmacol. 59:2000;741-751.
39. Puga A., Nebert D.W., Carrier F. Dioxin induces expression of c-fos and c-jun proto-oncogenes and a large increase in transcription factor AP-1. DNA Cell Biol. 11:1992;269-281.
40. Gohl G., Lehmkoster T., Munzel P.A., Schrenk D., Viebahn R., Bock K.W. TCDD-inducible plasminogen activator inhibitor type 2 (PAI-2) in human hepatocytes, HepG2 and monocytic U937 cells. Carcinogenesis. 17:1996;443-449.
41. Hoffer A., Chang C.-Y., Puga A. Dioxin induces fos and jun gene expression by Ah receptor dependent- and independent-pathways. Toxicol. Appl. Pharmacol. 141:1996;238-247.
42. Gille H., Kortenjann M., Strahl T., Shaw P.E. Phosphorylation-dependent formation of a quaternary complex at the c-fos SRE. Mol. Cell. Biol. 16:1996;1094-1102.
43. Cavigelli M., Dolfi F., Claret F.-X., Karin M. Induction of c-fos expression through JNK-mediated TCF/Elk-1 phosphorylation. EMBO J. 14:1995;5957-5964.
44. Sachsenmaier C., Radler-Pohl A., Muller A., Herrlich P., Rahmsdorf H.J. Damage to DNA by UV light and activation of transcription factors. Biochem. Pharmacol. 47:1994;129-136.
45. Okino S.T., Pendurthi U.R., Tukey R.H. Phorbol esters inhibit the dioxin receptor-mediated transcriptional activation of the mouse Cypla-1 and Cypla-2 genes by 2,3,7,8-tetrachlorodibenzo-p-dioxin. J. Biol. Chem. 267:1992;6991-6998.
46. Ikegwuonu F.I., Christou M., Jefcoate C.R. Regulation of cytochrome P4501B1 (CYP1B1) in mouse embryo fibroblast (C3H10T1/2) cells by protein kinase C (PKC). Biochem. Pharmacol. 57:1999;619-630.
47. Pongratz I., Strömstedt P.E., Mason G.G., Poellinger L. Inhibition of the specific DNA binding activity of the dioxin receptor by phosphatase treatment. J. Biol. Chem. 266:1991;16813-16817.
48. Mahon M.J., Gasiewicz T.A. Ah receptor phosphorylation: localization of phosphorylation sites to the C-terminal half of the protein. Arch. Biochem. Biophys. 318:1995;166-174.
49. Park S., Henry E.C., Gasiewicz T.A. Regulation of DNA binding activity of the ligand-activated aryl hydrocarbon receptor by tyrosine phosphorylation. Arch. Biochem. Biophys. 381:2000;302-312.
50. Li S.Y., Dougherty J.J. Inhibitors of serine/threonine-specific protein phosphatases stimulate transcription by the Ah receptor/Arnt dimer by affecting a step subsequent to XRE binding. Arch. Biochem. Biophys. 340:1997;73-82.
51. Dieter M.Z., Freshwater S.L., Solis W.A., Nebert D.W., Dalton T.P. Tryphostin AG879, a tyrosine kinase inhibitor: prevention of transcriptional activation of the electrophile and the aromatic hydrocarbon response elements. Biochem. Pharmacol. 61:2001;215-225.
52. Berghard A., Gradin K., Pongratz I., Whitelaw M.L., Poellinger L. Cross-coupling of signal transduction pathways: the dioxin receptor mediates induction of cytochrome P-450IA1 expression via a protein kinase C-dependent mechanism. Mol. Cell. Biol. 13:1993;677-689.
53. Levine S.L., Perdew G.H. Aryl hydrocarbon receptor (AhR)/AhR nuclear translocator (ARNT) activity is unaltered by phosphorylation of a periodicity/ARNT/single-minded (PAS)-region serine residue. Mol. Pharmacol. 59:2001;557-566.
54. Fantz D.A., Jacobs D., Glossip D., Kornfeld K. Docking sites on substrate proteins direct extracellular signal-regulated kinase to phosphorylate specific residues. J. Biol. Chem. 276:2001;27256-27265.
55. Reiners J.J. Jr., Jones C.L., Hong N., Clift R.E., Elferink C. Downregulation of aryl hydrocarbon receptor function and cytochrome P450 1A1 induction by expression of Ha-ras oncogenes. Mol. Carcinog. 19:1997;91-100.
56. Kobayashi A., Numayama-Tsuruta K., Sogawa K., Fujii-Kuriyama Y. CBP/p300 functions as a possible transcriptional coactivator of Ah receptor nuclear translocator (Arnt). J. Biochem. (Tokyo). 122:1997;703-710.
57. Kumar M.B., Tarpey R.W., Perdew G.H. Differential recruitment of coactivator RIP140 by Ah and estrogen receptors. Absence of a role for LXXLL motifs. J. Biol. Chem. 274:1999;22155-22164.
58. Kumar M.B., Perdew G.H. Nuclear receptor coactivator SRC-1 interacts with the Q-rich subdomain of the AhR and modulates its transactivation potential. Gene Expr. 8:1999;273-286.
59. Tohkin M., Fukuhara M., Elizondo G., Tomita S., Gonzalez F.J. Aryl hydrocarbon receptor is required for p300-mediated induction of DNA synthesis by adenovirus E1A. Mol. Pharmacol. 58:2000;845-851.
60. Peeper D.S., Upton T.M., Ladha M.H., Neuman E., Zalvide J., Bernards R., Decaprio J.A., Ewen M.E. Ras signalling linked to the cell-cycle machinery by the retinoblastoma protein. Nature. 386:1997;177-181.
61. Cheng M., Olivier P., Diehl J.A., Fero M., Roussel M.F., Roberts J.M., Sherr C.J. The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18:1999;1571-1583.
62. Sherr C.J., Roberts J.M. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1999;1501-1512.
63. Smits V.A., Medema R.H. Checking out the G(2)/M transition. Biochim. Biophys. Acta. 1519:2001;1-12.
64. Weiss C., Kolluri S.K., Kiefer F., Gottlicher M. Complementation of Ah receptor deficiency in hepatoma cells: negative feedback regulation and cell cycle control by the Ah receptor. Exp. Cell Res. 226:1996;154-163.
65. Ma Q., Whitlock J.P.J. The aromatic hydrocarbon receptor modulates the Hepa 1c1c7 cell cycle and differentiated state independently of dioxin. Mol. Cell. Biol. 16:1996;2144-2150.
66. kip1 induction and inhibition of proliferation by the intracellular Ah receptor in developing thymus and hepatoma cells. Genes Dev. 13:1999;1742-1753.
67. Puga A., Barnes S.J., Dalton T.P., Chang C., Knudsen E.S., Maier M.A. Aromatic hydrocarbon receptor interaction with the retinoblastoma protein potentiates repression of E2F-dependent transcription and cell cycle arrest. J. Biol. Chem. 275:2000;2943-2950.
68. Ge N.-L., Elferink C.J. A direct interaction between the aryl hydrocarbon receptor and retinoblastoma protein. J. Biol. Chem. 273:1998;22708-22713.
69. Elferink C.J., Ge N.L., Levine A. Maximal aryl hydrocarbon receptor activity depends on an interaction with the retinoblastoma protein. Mol. Pharmacol. 59:2001;664-673.
70. Elizondo G., Fernandez-Salguero P., Sheikh M.S., Kim G.Y., Fornace A.J., Lee K.S., Gonzalez F.J. Altered cell cycle control at the G(2)/M phases in aryl hydrocarbon receptor-null embryo fibroblast. Mol. Pharmacol. 57:2000;1056-1063.
71. Gierthy J.F., Crane D. Reversible inhibition of in vitro epithelial cell proliferation by 2,3,7,8-tetrachlorodibenzo-p-dioxin. Toxicol. Appl. Pharmacol. 74:1984;91-98.
72. Hushka D.R., Greenlee W.F. 2,3,7,8-Tetrachlorodibenzo-p-dioxin inhibits DNA synthesis in rat primary hepatocytes. Mutat. Res. 333:1995;89-99.
73. Bauman J.W., Goldsworthy T.L., Dunn C.S., Fox T.R. Inhibitory effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on rat hepatocyte proliferation induced by 2/3 partial hepatectomy. Cell Prolif. 28:1995;437-451.
74. Kumar M.B., Ramadoss P., Reen R.K., Vanden Heuvel J.P., Perdew G.H. The Q-rich sub-domain of the human Ah receptor transactivation domain is required for dioxin-mediated transcriptional activity. J. Biol. Chem. 276:2001;42302-42310.
75. Zarkowska T., Mittnacht S. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin-dependent kinases. J. Biol. Chem. 272:1997;12738-12746.
76. Weintraub S.J., Chow K.N., Luo R.X., Zhang S.H., He S., Dean D.C. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature. 375:1995;812-815.
77. Strobeck M.W., Fribourg A.F., Puga A., Knudsen E.S. Restoration of retinoblastoma mediated signaling to Cdk2 results in cell cycle arrest. Oncogene. 19:2000;1857-1867.
78. Strobeck M.W., Knudsen K.E., Fribourg A.F., DeCristofaro M.F., Weissman B.E., Imbalzano A.N., Knudsen E.S. BRG-1 is required for RB-mediated cell cycle arrest. Proc. Natl. Acad. Sci. USA. 97:2000;7748-7753.
79. Yang P., Schwartz A.G., McAllister A.E., Swanson G.M., Aston C.E. Lung cancer risk in families of nonsmoking probands: heterogeneity by age at diagnosis. Genet. Epidemiol. 17:1999;253-273.
80. Singh P., Coe J., Hong W. A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature. 374:1995;562-565.
81. Lu J., Danielsen M. Differential regulation of androgen and glucocorticoid receptors by retinoblastoma protein. J. Biol. Chem. 273:1998;31528-31533.
82. Sogawa K., Handa H., Fujisawa-Sehara A., Hiromasa T., Yamane M., Fujii-Kuriyama Y. Repression of cytochrome P-450c gene expression by cotransfection with adenovirus E1a DNA. Eur. J. Biochem. 181:1989;539-544.